Seven numbers in the abstract
Where each one falls
Only readable comparisons vote
Where it lands on the map
the abstract, start to end
Metformin (odds ratio (OR), 0.74; P=0.001), dipeptidyl peptidase-4 inhibitors (DPP4i) (OR, 0.88; P=0.04), sodium-glucose cotransporter-2 inhibitors (SGLT2i) (OR, 0.82; P=0.001), and glucagon-like peptide-1 receptor agonists (GLP1RA) (OR, 0.91; P=0.02) treatment were …
… resulted in higher mortality (OR, 1.8; P=0.001).
… differ in sulfonylurea (OR, 0.97; P=0.56) and thiazolidinediones (TZDs) (OR, 1.00; P=0.96) users.
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
Glycemic control
OR 0.74
Glycemic control
OR 0.88
Glycemic control
OR 0.82
Glycemic control
OR 0.91
All-cause mortality
OR 1.8
All-cause mortality
OR 0.97
All-cause mortality
OR 1.00
MetforminThiazolidinedionesInsulinGlycemic controlAll-cause mortality
1 / 4